Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclosporine (sandimmune) (2 trials)
lansoprazole (prevacid) (1 trial)
omeprazole (prilosec) (1 trial)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Trials (2 total)
Trial APIs (3 total)